Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02236897 · ClinicalTrials.gov registry record · NA
PET Imaging in ALS Patients
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT02236897: Completed NA study, sponsored by Johns Hopkins University.
NCT02236897 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02236897, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate a potential imaging biomarker for aiding diagnosis and monitoring progression of ALS, based on a well established basic science pathway, published human autopsy data, preliminary data in ALS mutant mice, and our recently published data using brain PET scans to image the metabotropic glutamate receptor type 5 (mGluR5) in healthy human volunteers.
Interventions
- OTHER PET Scanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02236897
The ClinicalTrials.gov registry entry for NCT02236897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET Scanning is the first listed.
NCT02236897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02236897 about?
NCT02236897 is a clinical study titled "PET Imaging in ALS Patients". This is a pilot study to evaluate a potential imaging biomarker for aiding diagnosis and monitoring progression of ALS, based on a well established basic science pathway, published human autopsy data, preliminary data in ALS mutant mice, and our recently published data using brain PET scans to image...
What is the current status of trial NCT02236897?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2013-08. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02236897?
The interventions under investigation include: PET Scanning (OTHER).
Who is sponsoring clinical trial NCT02236897?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.